NCT06323798 is a clinical trial of MRI in Pyocele; Sinus, sponsored by Central Hospital, Nancy, France.

Who is sponsoring NCT06323798?

NCT06323798 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT06323798?

Interventions in NCT06323798: MRI.

What condition does NCT06323798 study?

NCT06323798 studies Pyocele; Sinus.

Is NCT06323798 still recruiting?

NCT06323798 is currently status unknown. Last updated 21 March 2024.

Last reviewed 2024-03-21 · How we verify

NCT06323798

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diffusion Weighted MRI Enables Differential Diagnosis Between Pyocele and Mucocele

Status unknown Last updated 21 March 2024

What this trial tests

trial testing MRI in Pyocele; Sinus in 20 participants. Status unknown.

Timeline

28 April 2024

Primary endpoint
28 July 2024

28 December 2024

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	20
Start date	28 April 2024
Primary completion	28 July 2024
Estimated completion	28 December 2024

Drugs / interventions tested

MRI — full drug profile →

Conditions studied

Pyocele; Sinus — all drugs for Pyocele; Sinus →

Sponsor

Central Hospital, Nancy, France

Who can join

Adults 18 to 99, any sex, with Pyocele; Sinus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diffusion MRI should allow for differentation of pus and simple retention in the paranasal sinuses, but this remained to be determined

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
NCT07487870 — Radiographic Evaluation of Tumor Biology During Neoadjuvant Radiotherapy for Sarcoma · NA · not yet recruiting
NCT07567053 — Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study · NA · not yet recruiting
NCT07537504 — Language Function Reorganization in Patients With Arteriovenous Malformations · not yet recruiting
NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06323798 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 21 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06323798.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing